NAGE Q1 2018 Earnings — Niagen Bioscience Inc Revenue & Financial Results | Market Cap Arena

NAGENiagen Bioscience Inc

$393M

Q1 2018 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$7M+95.0% YoY

Gross Profit

$3M47.8% margin

Operating Income

-$8M-127.9% margin

Net Income

-$8M-128.6% margin

EPS (Diluted)

$-0.15

QoQ Revenue Growth

-12.8%

Cash Flow

Operating Cash Flow

-$4M

Free Cash Flow

-$4M

Stock-Based Comp.

$1M

Balance Sheet

Total Assets

$57M

Total Liabilities

$11M

Stockholders' Equity

$47M

Cash & Equivalents

$41M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$7M	$3M	+95.0%
Gross Profit	$3M	$2M	+93.9%
Operating Income	-$8M	-$2M	-373.7%
Net Income	-$8M	-$2M	-337.7%